share_log

StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)

證券新聞網啟動對中國製藥有限公司（紐約證交所代碼：CPHI）的報導
kopsource ·  2023/01/27 04:53

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a research report released on Tuesday morning. The brokerage issued a hold rating on the stock.

證券新聞網開始對股票的報導 中國製藥公司（紐約證券交易所代碼：CPHI — 獲得評級） 在星期二早上發布的研究報告中。該經紀公司對股票發出了持有評級。

China Pharma Price Performance

中國製藥價格表現

Shares of CPHI opened at $0.10 on Tuesday. The firm has a market capitalization of $5.42 million, a PE ratio of -1.31 and a beta of 0.69. China Pharma has a 1-year low of $0.08 and a 1-year high of $0.53. The company's fifty day moving average price is $0.11 and its 200-day moving average price is $0.15.

CPHI 的股份在星期二開市 0.10 美元。該公司的市值為 542 萬美元，私募股權比率為 -1.31，貝塔值為 0.69。中國製藥有 1 年低點 0.08 美元和 1 年新高 0.53 美元。該公司的五十天移動平均價為 0.11 美元，其 200 天移動平均價格為 0.15 美元。

Get
取得
China Pharma
中國製藥
alerts:
警報：

China Pharma Company Profile

中國製藥公司簡介

(Get Rating)

(取得評分)

China Pharma Holdings, Inc engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products.
中國醫藥控股有限公司從事醫藥產品的開發，製造和銷售。該公司的產品組合包括中樞神經系統（CNS）和腦心血管疾病，抗感染和呼吸系統疾病，消化系統疾病，綜合醫療保健和防護產品。

See Also

另請參閱

  • Get a free copy of the StockNews.com research report on China Pharma (CPHI)
  • Does Oil Services Firm NOV Have Enough Energy To Maintain Rally?
  • Shopify Clears Cup-With-Handle Base: Can Momentum Continue?
  • The Future Of E-Commerce: Analysis And New Data
  • Chevron Delights Shareholders with $75 Billion in Share Buybacks
  • Levi Strauss Is A Good Fit For Income Investors
  • 獲取有關中國醫藥研究報告的免費副本
  • 石油服務公司 NOV 是否有足夠的能量來維持反彈？
  • Shopify 清除了帶手柄的杯子底座：動力可以繼續嗎？
  • 電子商務的未來：分析與新數據
  • 雪佛龍以 750 億美元的股份回購令股東感到滿意
  • 列維·施特勞斯是一個非常適合收入投資者

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

接收《中國醫藥日報》的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收有關中國製藥及相關公司的最新新聞和分析師評級的簡要每日摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論